Orelabrutinib could be ‘preferred’ BTK inhibitor for MCLDecember 12, 2019Mantle Cell LymphomaB Cell Lymphoma
Efficacy of postvenetoclax therapy may depend on prior agent exposure in CLLDecember 10, 2019CLLB Cell Lymphoma
Think twice: Choosing Wisely recommendations on testing to avoid in pediatric hematologyDecember 10, 2019PediatricsAnemiaBleeding DisordersPatient & Survivor CareTransfusion Medicine
Oral arginine emerges as potential adjuvant for vaso-occlusive crisis managementDecember 9, 2019Anemia
Study halted; ‘hyperprogression’ seen with nivolumab for R/R PTCLDecember 9, 2019T Cell LymphomasAggressive Lymphomas
Care coordination, equity can eliminate disparities for nonwhite patients with DLBCLDecember 8, 2019DLBCLNon-Hodgkin Lymphoma
Off-the-shelf cellular therapy shows promise in the labDecember 8, 2019B Cell LymphomaCLLCellular Therapy
